Clinical trial
An Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
NCT03533517 is registered in ClinicalTrials.gov with Ancora Heart, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
- Lead sponsor
- Ancora Heart, Inc.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 23, 2018
- Completion date
- February 28, 2026
- Enrollment
- 22 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.